Wound Biologics Market Intelligence Report - Global Forecast to 2027

Wound Biologics Market Intelligence Report - Global Forecast to 2027

The Global Wound Biologics Market is projected to reach USD 7,175.51 million by 2027 from USD 4,241.55 million in 2021, at a CAGR 9.15% during the forecast period.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

• The Americas Wound Biologics Market size was estimated at USD 1,467.38 million in 2021 and expected to reach USD 1,575.05 million in 2022, at a CAGR 8.89% to reach USD 2,447.40 million by 2027.
• The Asia-Pacific Wound Biologics Market size was estimated at USD 980.64 million in 2021 and expected to reach USD 1,083.12 million in 2022, at a CAGR 9.91% to reach USD 1,729.61 million by 2027.
• The Europe, Middle East & Africa Wound Biologics Market size was estimated at USD 1,793.51 million in 2021 and expected to reach USD 1,927.44 million in 2022, at a CAGR 8.94% to reach USD 2,998.49 million by 2027.

Market Segmentation & Coverage:

The report on wound biologics identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.

This research report categorizes the wound biologics to forecast the revenues and analyze the trends in each of the following sub-markets:

Product:

• Biologic Skin Substitutes
  • Acellular Animal-derived Products
  • Biosynthetic Products
  • Human Donor Tissue-derived Products
• Topical Agents

Wound Type:

• Burns
• Surgical and Traumatic Wounds
• Ulcers
  • Diabetic Foot Ulcers
  • Pressure Ulcers
  • Venous Ulcers

End-User:

• Ambulatory Surgery Centers
• Burn Centers
• Hospitals
• Wound Clinics

Region:

• Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
    • California
    • Connecticut
    • Florida
    • Illinois
    • Maryland
    • Minnesota
    • New Jersey
    • New York
    • Ohio
    • Pennsylvania
    • Texas
    • Washington
• Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
• Europe, Middle East & Africa
  • France
  • Germany
  • Italy
  • Netherlands
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • United Arab Emirates
  • United Kingdom

Company Usability Profiles:

• 3M Company
• Anika Therapeutics, Inc
• Avita Medical, Inc.
• Bioventus Inc.
• ConvaTec Group PLC
• Cytori Therapeutics Inc.
• Integra Lifesciences Holdings Corporation
• Kerecis hf
• Marine Polymer Technologies, Inc.
• MIMEDX GROUP, INC.
• Mölnlycke Health Care AB
• Nuo Therapeutics, Inc.
• Organogenesis Inc.
• Skye Biologics Holdings, LLC
• Smith & Nephew PLC
• Stability Biologics
• Stryker Corporation
• Tides Medical
• Vericel Corporation
• Viatris Inc.

Currency: USD

Base Year: 2021

Estimated Year: 2022

Forecast Year: 2027

Base Year Value: USD 4,241.55 million

Estimated Year Value: USD 4,585.62 million

Forecast Year Value: USD 7,175.51 million

CAGR (%): 9.15%.

Please Note: PDF & Excel + Online Access - 1 Year